Alnylam Pharmaceuticals
ALNY
#608
Rank
$31.54 B
Marketcap
$226.28
Share price
-6.98%
Change (1 day)
48.47%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company